Skip to main content
SpringerLink
Log in

Low Urine Citrate/Magnesium/Potassium

  • Chapter
  • First Online:
Nutrition Therapy for Urolithiasis

  • 788 Accesses

Abstract

Citrate is the most abundant organic ion in urine and a potent natural inhibitor of calcium oxalate and calcium phosphate nucleation. Most of the orally ingested citrate gets converted to bicarbonate conferring an alkali load which may result in increased urine pH depending on concomitant acid load [1].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Agarwal MM, et al. Preventive fluid and dietary therapy for urolithiasis: an appraisal of strength, controversies and lacunae of current literature. Indian J Urol. 2011;27(3):310–9.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Heilberg I, Goldfarb D. Optimum nutrition for kidney stone disease. Adv Chronic Kidney Dis. 2013;20(2):165–74.

    Article  PubMed  Google Scholar 

  3. Pak CY. Hypercalciuric calcium nephrolithiasis. Philadelphia: WB Saunders; 1990.

    Google Scholar 

  4. Parks JH, Coe FL. A urinary calcium-citrate index for the evaluation of nephrolithiasis. Kidney Int. 1986;30(1):85–90.

    Article  CAS  PubMed  Google Scholar 

  5. Ferrandino M, Pietrow P, Preminger G. Evaluation and medical management of urinary lithiasis. Campbell-Walsh Urol, chapter 46. p. 1287–323.e8.

    Google Scholar 

  6. Caruana RJ, Buckalew VM Jr. The syndrome of distal (type 1) renal tubular acidosis. Clinical and laboratory findings in 58 cases. Medicine (Baltimore). 1988;67(2):84–99.

    Article  CAS  Google Scholar 

  7. Preminger GM, Pak CY. The practical evaluation and selective medical management of nephrolithiasis. Semin Urol. 1985;3(3):170–84.

    CAS  PubMed  Google Scholar 

  8. Pak CY, Fuller C, et al. Long-term treatment of calcium nephrolithiasis with potassium citrate. J Urol. 1985;134(1):11–9.

    Article  CAS  PubMed  Google Scholar 

  9. Welch BJ, Graybeal D, Moe OW, Maalouf NM, Sakhaee K. Biochemical and stone-risk profiles with topiramate treatment. Am J Kidney Dis. 2006;48(4):555–63.

    Article  CAS  PubMed  Google Scholar 

  10. Penniston KL, Nakada SY, Holmes RP, Assimos DG. Quantitative assessment of citric acid in lemon juice, lime juice, and commercially available fruit juice products. J Endourol. 2008;22:567–70.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Curhan GC, Willett WC, Rimm ED, Spiegelman D, Stampfer MJ. Prospective study of beverage use and the risk of kidney stones. Am J Epidemiol. 1996;143:240–7.

    Article  CAS  PubMed  Google Scholar 

  12. Kang DE, Sur RL, Haleblian GE, Fitzsimons NJ, Borawski KM, Preminger GM. Long-term lemonade based dietary manipulation in patients with hypocitraturic nephrolithiasis. J Urol. 2007;177:1358–62.

    Article  PubMed  Google Scholar 

  13. Curhan GC, Willett WC, Rimm EB, Stampfer MJ. A prospective study of the intake of vitamins C and B6, and the risk of kidney stones in men. J Urol. 1996;155(6):1847–51.

    Article  CAS  PubMed  Google Scholar 

  14. Curhan GC, Willett WC, Speizer FE, Stampfer MJ. Beverage use and risk for kidney stones in women. Ann Intern Med. 1998;128(7):534–40.

    Article  CAS  PubMed  Google Scholar 

  15. Eisner BH, Asplin JR, Goldfarb DS, Ahmad A, Stoller ML. Citrate, malate and alkali content in commonly consumed diet sodas: implications for nephrolithiasis treatment. J Urol. 2010;183(6):2419–23.

    Article  CAS  PubMed  Google Scholar 

  16. Pearle MS, et al. Medical management of kidney stones: AUA guideline. J Urol. 2014;192(2):316–24.

    Article  PubMed  Google Scholar 

  17. Taylor EN, Fung TT, Curhan GC. DASH-style diet associates with reduced risk for kidney stones. J Am Soc Nephrol. 2009;20(10):2253–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Gettman MT, Ogan K, Brinkley LJ, Adams-Huet B, Pak CY, Pearle MS. Effect of cranberry juice consumption on urinary stone risk factors. J Urol. 2005;174(2):590–4.

    Article  CAS  PubMed  Google Scholar 

  19. Baxmann AC, De OG, Mendonça C, Heilberg IP. Effect of vitamin C supplements on urinary oxalate and pH in calcium stone forming patients. Kidney Int. 2003;63(3):1066–71.

    Article  CAS  PubMed  Google Scholar 

  20. Yilmaz E, Batislam E, Basar M, Tuglu D, Erguder I. Citrate levels in fresh tomato juice: a possible dietary alternative to traditional citrate supplementation in stone-forming patients. Urology. 2008;71(3):379–83.

    Article  PubMed  Google Scholar 

  21. Baia LD, Baxmann AC, Moreira SR, Holmes RP, Heilberg IP. Noncitrus alkaline fruit: a dietary alternative for the treatment of hypocitraturic stone formers. J Endourol. 2012;26:1221–6.

    Article  Google Scholar 

  22. Goodman JW, Asplin JR, Goldfarb DS. Effect of two sports drinks on urinary lithogenicity. Urol Res. 2009;37(1):41–6.

    Article  CAS  PubMed  Google Scholar 

  23. Massey L. Magnesium therapy for nephrolithiasis. Magnes Res. 2005;18(2):123–6.

    CAS  PubMed  Google Scholar 

  24. Rodgers A. Aspects of calcium oxalate crystallization: theory, in vitro studies and in vivo implementation. J Am Soc Nephrol. 1999;10:S351–4.

    CAS  PubMed  Google Scholar 

  25. Allie S, Rodgers A. Effects of calcium carbonate, magnesium oxide and sodium citrate bicarbonate health supplements on the urinary risk factors for kidney stone formation. Clin Chem Lab Med. 2003;41:39–45.

    Article  CAS  PubMed  Google Scholar 

  26. Grases F, Rodriguez A, Costa-Bauza A. Efficacy of mixtures of magnesium, citrate and phytate as calcium oxalate crystallization inhibitors in urine. J Urol. 2015;194(3):812–9. pii: S0022-5347(15)03461-8

    Article  CAS  PubMed  Google Scholar 

  27. Liebman M, Costa G. Effects of calcium and magnesium on urinary oxalate excretion after oxalate loads. J Urol. 2000;163:1565–9.

    Article  CAS  PubMed  Google Scholar 

  28. Berg W, Bothor C, Pirlich W, Janitzky V. Influence of magnesium on the absorption and excretion of calcium and oxalate ions. Eur Urol. 1986;12:274–82.

    Article  CAS  PubMed  Google Scholar 

  29. Barilla DE, Notz C, et al. Renal oxalate excretion following oral oxalate loads in patients with ileal disease and with renal and absorptive hypercalciurias. Effect of calcium and magnesium. Am J Med. 1978;64(4):579–85.

    Article  CAS  PubMed  Google Scholar 

  30. Ranade VV, Somberg JC. Bioavailability and pharmacokinetics of magnesium after administration of magnesium salts to humans. Am J Ther. 2001;8:345–57.

    Article  CAS  PubMed  Google Scholar 

  31. Fetner CD, Barilla DE, et al. Effects of magnesium oxide on the crystallization of calcium salts in urine in patients with recurrent nephrolithiasis. J Urol. 1978;120(4):399–401.

    Article  CAS  PubMed  Google Scholar 

  32. Tiselius HG, Ahlstrand C, et al. Urine composition in patients with urolithiasis during treatment with magnesium oxide. Urol Res. 1980;8(4):197–206.

    Article  CAS  PubMed  Google Scholar 

  33. Ettinger B. Potassium-magnesium citrate is an effective prophylaxis against recurrent calcium oxalate nephrolithiasis. J Urol. 1997;158(6):2069–73.

    Article  CAS  PubMed  Google Scholar 

  34. Taylor EN, Stampfer MJ, Curhan GC. Dietary factors and the risk of incident kidney stones in men: new insights after 14 years of follow-up. J Am Soc Nephrol. 2004;15:3225–32.

    Article  PubMed  Google Scholar 

  35. Fourman P, Robinson JR. Diminished urinary excretion of citrate during deficiencies of potassium in man. Lancet. 1953;2:656–7.

    Article  Google Scholar 

  36. Adam WR, Koretsky AP, Weiner MW. 31P-NMR in vivo measurement of renal intracellular pH: effects of acidosis and K+ depletion in rats. Am J Phys. 1986;251:F904–10.

    CAS  Google Scholar 

  37. Jenkins AD, Dousa TP, Smith LH. Transport of citrate across renal brush border membrane: effects of dietary acid and alkali loading. Am J Phys. 1985;249:F590–5.

    CAS  Google Scholar 

  38. Domrongkitchaiporn S, Stitchantrakul W, Kochakarn. Causes of hypocitraturia: focusing on urinary citrate excretion. Am J Kidney Dis. 2006;48(4):546–54.

    Article  CAS  PubMed  Google Scholar 

  39. Curhan GC, Willett WC, Rimm EB, Stampfer MJ. A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N Engl J Med. 1993;328:833–8.

    Article  CAS  PubMed  Google Scholar 

  40. Taylor EN, Curhan GC. Demographic, dietary, and urinary factors and 24-h urinary calcium excretion. Clin J Am Soc Nephrol. 2009;4:1980–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Cirillo M, Laurenzi M, Panarelli W, Stamler J. Urinary sodium to potassium ratio and urinary stone disease: the Gubbio Population Study Research Group. Kidney Int. 1994;46:1133–9.

    Article  CAS  PubMed  Google Scholar 

  42. Qaseem A. Dietary and pharmacologic management to prevent recurrent nephrolithiasis in adults: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2014;161:659–667.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Nephrology and Hypertension, Baylor Scott and White Healthcare, Temple, TX, USA

    Fysal AlBaalbaki MD & Mohanram Narayanan MD, FACP, FASN, FNKF

Authors
  1. Fysal AlBaalbaki MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mohanram Narayanan MD, FACP, FASN, FNKF
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mohanram Narayanan MD, FACP, FASN, FNKF .

Editor information

Editors and Affiliations

  1. Department of Surgery, Division of Urology, Texas A&M HSC College of Medicine, Scott & White Healthcare, Temple, Texas, USA

    Patrick Lowry

  2. Department of Urology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA

    Kristina L. Penniston

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

AlBaalbaki, F., Narayanan, M. (2018). Low Urine Citrate/Magnesium/Potassium. In: Lowry, P., Penniston, K. (eds) Nutrition Therapy for Urolithiasis. Springer, Cham. https://doi.org/10.1007/978-3-319-16414-4_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-16414-4_9

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-16413-7

  • Online ISBN: 978-3-319-16414-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation